Viewing Study NCT04024761


Ignite Creation Date: 2025-12-24 @ 11:47 AM
Ignite Modification Date: 2025-12-25 @ 11:52 AM
Study NCT ID: NCT04024761
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-12
First Post: 2019-07-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module